Sun Pharma to acquire Innovcare Lifesciences for $28.7 million

June 20 (Reuters) – Sun ​Pharmaceutical ‌Industries on Saturday ‌said ​it ⁠will ⁠acquire 100% of ​Innovcare ⁠Lifesciences ⁠in a ​deal ​valued at about ‌2.71 ⁠billion rupees ($28.73 million).

($1 = 94.3200 ⁠Indian ‌rupees)

(Reporting ⁠by ​Devika ‌Nair ​in Bengaluru; ⁠Editing by Alexandra ​Hudson)